3,5-dibromosalicylic acid has been researched along with bosentan anhydrous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blandin, V; Breittmayer, JP; Frelin, C; Vigne, P | 1 |
1 other study(ies) available for 3,5-dibromosalicylic acid and bosentan anhydrous
Article | Year |
---|---|
Allosteric inhibition of endothelin ETA receptors by 3, 5-dibromosalicylic acid.
Topics: Allosteric Regulation; Animals; Aorta; Benzoic Acid; Biological Transport; Bosentan; Bromobenzoates; Calcium; Cells, Cultured; Chromatography, Gel; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Iodine Radioisotopes; Peptides, Cyclic; Rats; Receptor, Endothelin A; Receptors, Endothelin; Recombinant Proteins; Salicylates; Salicylic Acid; Solubility; Sulfonamides; Vasodilation | 2000 |